Introduction
The fundamental causes of the rise in obesity in developed and increasingly in developing countries are unknown but are thought to relate to a change in energy balance resulting from the reduced energy expenditure associated with increasingly sedentary lifestyles and energy dense diets (1, 2) . The cultural effects on body weight observed after people migrate to Western countries and the rapid changes in the prevalence of obesity (occurring over a single generation) point to a significant role for environmental causes, such as socioeconomic and cultural factors (3) . Genetic factors are also very important: substantial evidence for a genetic component in body weight regulation and adiposity comes from family, twin, and adoption studies (4, 5) . Heritability estimates reported from family studies are in the range of 25% to 40%, and for twin studies in the range of 50% to 80% (6) . The complex interaction between inherited susceptibility to and high-risk environments for developing obesity mean that approaches to obesity management should consider all of these causes (7) .
Both linkage and association analysis have been used to attempt to find susceptibility genes for BMI and obesity. Although the linkage approach in particular has been successful in identifying the 6 known single-gene forms of obesity (8) , these are very rare in the general population, accounting for Ͻ1% of cases.
There have been more than 30 genome-wide linkage scans and several hundred candidate gene association studies of BMI, and approximately 10 genome-wide linkage scans of obesity, with a variety of loci and genes implicated in the disorder (9) . However, no susceptibility genes for common, complex forms of obesity or body weight regulation have been unequivocally identified by these methods. Individual genome-wide scans for linkage have identified a number of genetic loci that reach significance criteria, and some of these have appeared in more than one study, such as those on chromosomes 2p, 6q, 20p (8) . Thus, although evidence has emerged for specific loci linked to BMI and obesity (9) , none has been consistently implicated in the majority of genome scan projects.
There are many possible explanations for the observed inconsistency of results of linkage scans using BMI as a phenotype. Some of these are methodological, and others relate to disease etiology, such as locus heterogeneity (i.e., more than one separate genetic susceptibility loci), the involvement of different biological pathways, genetic and environmental differences between populations, variability in ascertainment criteria, and so on. If there is extensive heterogeneity, each locus is likely to have a small population-wide effect on susceptibility to obesity or on BMI, which is difficult to detect consistently without very large samples.
Methodological factors influencing consistency of linkage studies may include differences in statistical strategies, the reporting of spurious loci more than once (given the large number of studies), or differences in sample size and statistical power (10) . Many studies of BMI and obesity have used small sample sizes, although some large studies [e.g., National Heart, Lung, and Blood Institute Family Heart Study (11) ] do exist. Strategies that might overcome these problems include very large population-based linkage studies, which would increase statistical power, studies that take into account environmental factors, or genome-wide association strategies, all of which should be able to detect genes of smaller effect.
Another possibility is meta-analysis of linkage data, where the gain in statistical power might overcome the problems of locus heterogeneity and clarify the role of individual loci and assist the mapping effort. Consequently, we applied the rank-based genome scan meta-analysis (GSMA) 1 method (12) to data from the 37 complete genome scans of BMI, 10 of which are specifically for obesity. The GSMA is a widely used nonparametric method for combining results from published genome scans and can be applied to a combination of studies with different markers, family structures, and analysis methods. In previous studies, the method has identified significant evidence for linkage that was not evident in the individual studies (13) (14) (15) . If loci with small effect, consistent across studies, exist for BMI or obesity, then this approach would have power to identify them.
Research Methods and Procedures

GSMA Method
The genome was divided into 120 bins of approximately 30 cM. For each study, results were assigned to bins, and the strongest evidence for linkage within each bin was identified [e.g., the highest logarithm of odds (LOD)-, Z-or non-parametric linkage (NPL)-score, or the minimum p value]. For most studies, evidence for linkage for each bin [LOD scores, NPL scores, maximum likelihood scores (MLS), or p values] was taken directly from graphs of genome-wide linkage results as published in the original papers. Each graph was imported into a drawing program (CorelDraw) and overlaid with a grid dividing each chromosome equally into the required number of bins. These were then ranked in order of evidence for linkage by measuring the peak height within each bin using a graphical ruler from within the drawing program. For the remaining studies (16 -31) , linkage scores were obtained by request from the study authors, who sent us the full genome-scan results. A control comparison between ranks estimated this way, and those from linkage results data for the same study showed correlation of Ͼ0.9. For studies (11, 17, 20, 23, 24, 27, (32) (33) (34) where results included marker names, bins were determined using predefined markers (see www.kcl.ac.uk/depsta/memoge/gsma/bin_definitions.html for listing of bin boundary markers). For all other studies, each chromosome was divided into equal width bins. Bins are referred to by chromosome, so "bin 1.4" indicates the fourth bin on chromosome 1.
The data for the GSMA consist of a maximum linkage statistic for each study and each bin. Within each study, the bins are ranked, with the bin achieving maximum evidence for linkage assigned rank 120. For each bin, the ranks are then summed across studies, and this summed rank forms the test statistic for that bin. Under the null hypothesis of no linkage, the summed rank is the sum of random ranks chosen from (1, 2, Ͼ.120) with replacement. Bins with high summed ranks therefore show evidence for linkage.
The summed rank is tested for significance by simulation, permuting the bin location of ranks within each study. For each bin, two tests of significance are performed. The summed rank p value is equal to the proportion of simulated bins with summed rank greater or equal to the observed summed rank. For the ordered rank p value, the "place" of the bin's result is noted, and compared with the summed rank of bins with the same "place" in each simulated GSMA. So, for the observed highest summed rank, the ordered rank p value is calculated from the summed ranks of the bins attaining highest summed rank in each GSMA simulation. Similarly, the second highest summed rank is compared with the second highest values in each complete simulation. Simulation studies have shown that bins with both significant summed rank and ordered rank p values have a higher probability of being true linkage findings (35) .
We used three different thresholds for significance: genome-wide significance using a Bonferroni correction for testing 120 bins (p ϭ 0.05/120 ϭ 0.00042), suggestive significance expected to occur once in each GSMA study (p ϭ 1/120 ϭ 0.0083), and nominal significance (p ϭ 0.05).
The GSMA analysis was carried using the GSMA software (36), available from http://www.kcl.ac.uk/depsta/ memoge/gsma/download.html, with p values based on 10,000 simulations. Analyses were performed unweighted and weighted for study size. In the weighted analysis, ranks were multiplied by the study weight before summation across studies (see below for choice of weighting function).
Ascertainment of Studies
The inclusion criteria for studies in this meta-analysis were whole genome scans of BMI, analyzed both as quantitative and categorical trait. The latter was defined by dichotomization of BMI at a cut-off point. Our underlying hypothesis is that the same quantitative trait loci will influence variation to both BMI and BMI-defined obesity, which we think is a reasonable hypothesis given the scarcity of single-gene forms of obesity and the fact that BMI-defined obesity is very common (BMI Ն30 in more than Ͼ25% of the U.S. population; http://www.cdc.gov/nccdphp/dnpa/obesity/ trend/maps/index.htm). Studies were identified in two main ways. Whole genome scans were identified from the obesity gene database (37) or were selected by using searches for combinations of "genome scan," "genome search," "linkage," "BMI," "body mass index," and "obesity" using Medline, searching between April and July 2004. Some additional studies were identified on an ad hoc basis, from the cited references in other papers (30) cited by a previous meta-analysis (38) , or using internet Web-based search engines (39) . In addition, we included data from our own unpublished linkage study of BMI [using the Genetic and Environmental Nature of Emotional States in Siblings (GENESIS) sample described by Nash et al. (17) ] and one based on the Finland-United States Investigation of NIDDM Genetics (FUSION) sample described by Silander et al. (31) . These studies were included because we were aware of the data from our own study, and data from the Silander et al., study was offered to us by the investigators as it was a direct, independent extension of the initial FUSION study by Watanabe et al. (30) . The inclusion of these studies based on our awareness of them should not introduce bias into our analysis, as their inclusion is independent of the results obtained in any specific genome region. All included studies were identified by July 2004, except Watanabe et al. (30) , which was included in July 2005. Studies that investigated linkage in only one region were excluded because the GSMA method is based on ranking linkage information across the entire genome.
To ensure that individual studies were included only once, certain decisions were made about which papers to include, because some studies are represented in the literature multiple times (e.g., as an individual study and as part of a meta-analysis). The data from the Framingham Heart Study gave a particular problem (40) because several different analyses of genome-wide linkage for BMI have been carried out on the same data (41) (42) (43) (44) (45) (46) (47) (48) (49) . A subset of the Framingham data, however, has also been included as part of a further study (11) and so this further study, but none of the additional or original analyses, was included. The results of Lee et al. (50) were a subset of a second analysis (19) and were excluded. Genome scans of obesity traits other than BMI-defined obesity, such as leptin or other anthropometric measures, were excluded in an attempt to perform a metaanalysis on a relatively homogenous phenotype. Studies whose analyses were primarily assessing parent of origin effects on BMI, e.g., (51), were also excluded.
Despite these strict inclusion criteria, 37 genome-wide linkage analyses of BMI were eligible for inclusion (11,16 -34,39,52-57) . These include the two unpublished genomewide linkage analyses of BMI: one based on the sample included in Nash et al. (17) and one based on the sample of Silander et al. (31) . The study from Wu et al. (53) included 8 scans, which were analyzed separately. 34 of 37 included studies have authors listed for this meta-analysis as part of the GSMA-BMI consortium. Table 1 gives details of the ascertainment criteria and the sampling populations for the studies included in this analysis, and a summary of the analysis methods used in the original studies. We were not able to obtain data from one published study (58) .
With regards to the studies with obesity as ascertainment criteria, 10 published genome-wide linkage studies were identified, 7 of which used BMI as a categorical trait to define obesity (i.e., obesity ϭ BMI Ͼ30 kg/m2) and 3 of which used BMI as a quantitative trait. In 2 of the 10 studies, obesity was investigated in childhood/adolescence, and in these the family ascertainment criteria were a proband with BMI Ͼ95th centile and a sibling with BMI Ͼ90th or Ͼ95th centile, respectively (29, 52) . The ascertainment criteria for the proband in the adult studies were extreme BMI (Ն35 or BMI Ն40), and for the siblings, a BMI cut-off point of between Ն27 and Ն40. Table 1 gives further details of the obesity studies.
Some studies performed different analyses and/or considered different BMI phenotypes. Stone et al. (20) looked at three phenotypes (BMI, BMI in females, and BMI in males) and performed four different parametric and nonparametric analyses. We used the results of the analysis across both sexes and considered for each bin the maximum LOD score obtained from the parametric linkage analysis across dominant, codominant, and recessive models. Li et al. (19) analyzed 4 different thresholds for obesity status; we used the linkage results from only one of these in the metaanalysis, the cut-off point at BMI Ն30. The majority of studies did not examine linkage by sex and did not include the X chromosome resulting in too few studies to attain sufficient statistical power for their analysis. Consequently, the GSMA analysis was not performed separately for males and females, nor was the X chromosome included. Likewise, the majority of studies did not stratify patients by age but used a range of age groups within and between families, and only two analyzed children only. Thus, we did not perform stratification by age.
GSMA Analyses
To identify potential common susceptibility loci for both BMI and obesity, a combined analysis including all of the 37 genome-wide analyses was performed. For studies where BMI was analyzed as quantitative trait, weighting by the number of genotyped individuals was used. This was scaled to give an average weight of 1. Weights ranged from 0.30 to 4.6. For obesity studies where BMI was analyzed as a categorical trait, a weighting function of the number of affected individuals was used, giving a maximum weight of 2.4 and a minimum weight of 0.5. Separate weighting schemes were chosen to reflect the approximate informativeness of each individual: for the obesity studies where BMI was analyzed as a categorical trait, each affected individual will contribute more information than a genotyped individual in the studies where BMI was analyzed as a continuous trait, whose phenotype is not selected for the tail of the distribution. For the pooled analysis, adjusted study weights were used, so analysis consisted of 28 "continuous trait" studies with a mean weight of 1, and 7 "categorical trait" studies, with a mean weight of 1.
Two studies, Li et al. (19) and Stone et al. (20) , reported data with BMI analyzed both as a continuous and a categorical trait, and both analyses were used in the metaanalysis. In the Li et al. study (19) , results from the categorical and quantitative analysis are quite discordant, so they were included in the meta-analysis as if they had been independent studies. However, the two Stone analyses show a strong concordance in results, each set of results was therefore weighted by one half the original weighting factors calculated for the Stone et al. (20) datasets. Genomewide linkage for BMI was calculated in FUSION 1 study (30) separately for subjects with type 2 diabetes and their unaffected spouses/children; and although the same families were used, the results are considered independently as study subjects were only included in one of the two analyses.
Two major sources of heterogeneity in the linkage studies are the phenotype of ascertainment and population. BMI is an easily measured phenotype, and in some studies the 
Results
Results for the meta-analyses of all of the BMI studies (pooled analysis) and of the obesity studies, weighted by study size are shown in Figure 1A and B, which shows genome-wide results (i.e., with a Bonferroni correction for testing 120 bins) with thresholds for significance (1%, 5%, 10%). Results for the subgroup analyses (pooled, obesity, diabetes, hypertension, and subjects with European ancestry) are shown in Figure 2 , which lists bins achieving a nominally significant summed rank (p value Ͼ0.05) for the weighted (pW) or unweighted analyses (pU). No bin achieved significant evidence for linkage at a genome-wide level (p Ͻ 0.00042), and few bins achieved suggestive evidence for linkage (p Ͻ 0.0083). For most analyses, there was strong consistency across the bins identified in the weighted and unweighted analysis. We focus on the weighted analysis in reporting results. Bins 13.2 or 13.3 reached suggestive evidence for linkage in the pooled analysis (bin 13.2 pW Ͻ 0.009; bin 13.3 pW ϭ 0.008), and nominal significance in families ascertained through obesity (bin 13.3 pU ϭ 0.019), with European ancestry (bin 13.2 pW ϭ 0.016; bin 13.3 pW ϭ 0.011), and in families ascertained for hypertension (bin 13.3 pW ϭ 0.029). Significant results in adjacent bins are a common finding in GSMA studies, and are due to the correlation of ranks in adjacent bins, particularly when multipoint analysis methods have been used in the original studies.
Several other regions were implicated by pooled or ascertainment-specific analyses. Bin 12.5 showed a suggestive evidence for linkage in the pooled analysis (pU ϭ 0.004) and a nominal significance in the families ascertained through obesity or hypertension. The FTO obesity gene locus at 16q12.2 (59) showed nominal evidence for linkage in the pooled analysis of obesity in bin 16.3. Bins 2.2, 9.5, 11.3, 11.4, 11.5, 17.2, and 17.3 also achieved a summed rank p value Յ0.05 in two of the five different analyses. Summed rank p values Յ0.01 were obtained not only in the pooled analysis (bins 13.2, 13.3, 12.5), but also in the obesity analysis at bin 11.3 (pU ϭ 0.007), for the families ascertained through diabetes at bins 17.3 (pW ϭ 0.007) and 4.3 (pU Ͻ 0.001), for the families ascertained through hypertension at bins 12.3, 9.5, and 12.4 (pW ϭ 0.004, pW ϭ 0.007, and pW ϭ 0.008, respectively) and for the European ancestry group at bin 13.3.
The GSMA uses multiple-testing of 120 bins, so about 6 bins would be expected to attain p Ͻ 0.05 in each analysis. This is consistent with the number of significant bins in the BMI (pooled analysis), and in the obesity status, European ancestry, and diabetic subgroup analyses. No significant ordered rank p values were observed in these analyses. However, in the hypertensive subgroup (9 studies), stronger evidence for linkage was seen, with 3 bins obtaining a p value Ͻ0.01 and six further bins attaining a summed rank p value pW Ͻ 0.05. In the hypertension analysis, bins 12.5 and 13.3, which arose across different analyses, reached also ordered rank p values Ͻ 0.05, increasing the evidence of the existence of susceptibility genes in these regions.
Discussion
We found several regions of the genome that provided suggestive or nominal evidence of linkage to BMI. Bins at chromosome 13q13.2-q33.1 (bins 13.2, 13.3) and 12q23-q24.3 (bin 12.5) achieved a suggestive evidence of linkage for BMI in both the pooled weighted or unweighted analysis, and nominal evidence in the unweighted analysis of the obesity studies. In this latter analysis, suggestive evidence of linkage was observed in the region 11p12-q13.3 (bin 11.3).
However, the results from the GSMA of 37 genome-wide scans on BMI and of 10 specific genome screens on obesity do not provide strong evidence for any particular region being consistently implicated in the genetic contribution to either trait. This is reflected by the fact that, in both the pooled and the obesity analyses, the distribution of summed rank p values Ͻ0.05 is not different from that expected by chance, under the hypothesis of no linkage, with ordered rank p values Ͼ0.05 for each bin. Moreover, our results do not seem to highlight any common region implicated in both traits. In contrast, a previous GSMA meta-analysis of linkage scans for BMI as a continuous trait was based on data from only five studies (16, 18, 32, 33, 58 ) from 13 studies initially targeted for inclusion. We included data only from those studies for which the authors provided data, despite the fact that this is not necessary where genome-wide data (for example, in the form of figures) is included in the publication. The data from the five studies included 2814 individuals from 505 families (38) , and using the same analysis methods, showed strong evidence of linkage to chromosome 8p. The five studies included were heteroge-neous with respect to both ethnicity and ascertainment, which were respectively hypertension, osteoporosis diabetes, random house-to-house recruitment, and finally obesity, familial dyslipidemia, migraine, osteoarthritis, and hypertension. Thus, the fact that Johnson et al. (38) obtained a positive result whereas we did not is unlikely to result from reduced heterogeneity in their sample.
The results presented here are therefore somewhat surprising, given that this meta-analysis represents a very large number of linkage studies, encompassing data from more than 10,000 families and over 31,000 individuals (including four of the five studies considered previously) and for two traits that are substantially heritable. It is not compatible with common major loci governing BMI and obesity in the general population but points toward the existence of many genes of small effect.
The most likely explanation for our failure to find strongly positive loci is not lack of statistical power, but the presence of substantial locus heterogeneity (involving several biological systems affecting appetite, behavior, activity levels, metabolism, as well as genetic variation between ethnic groups and according to ascertainment criteria), epistasis, and age-dependent effects. Obesity in rodents is clearly highly heterogeneous, where studies of mice indicate the presence of overlapping combinations of main and epistatic effects at adjacent ages, which have opposite effects on early and late growth. Body composition traits in mice seem to be influenced by an interacting network of multiple quantitative trait loci, which are shared by the body composition and body weight traits, suggesting that pleiotropy plays an important role in growth and obesity (60) . The failure to find loci with genome-wide significance could be partly related to the characteristics of BMI as a phenotype. BMI is the most easily measured proxy for obesity but 1) is a composite of fat and nonfat mass (the latter including bone mass), which are not likely to be regulated in the same way, and 2) may not always represent body fat consistently since the relationship between BMI and fat-mass is not always linear and often shows subgroup differences. Although high BMI values may principally be because of adiposity, in individuals nearer the mean high BMI may be more influenced by other features of body composition such as bone and muscle mass. This may be a particular problem for population-based studies where the majority of individuals are not obese and lie close to the mean. Despite this, it is worth reiterating that BMI is a highly reproducible and heritable phenotype, and the results we observe cannot be a result of flaws in the phenotype alone. Nevertheless, it is likely that more direct measures of adiposity would improve the consistency of linkage analysis, and it would be interesting to see what a meta-analysis of a more specific measure of body fat (e.g., percent body fat, total abdominal fat, or abdominal visceral fat) would show. However, at present, there are too few linkage studies of these phenotypes (9) to make a meta-analysis viable, in our opinion. The GSMA method itself has several limitations, and these are discussed in detail elsewhere. The method should have high power to detect genes that can be detected in a linkage analysis (35) , although it is difficult to assess the power of this specific study. GSMA might fail to detect linkage to loci where genetic heterogeneity is present, either across studies (because of population differences) or within studies (only a subset of families linked). Tests for heterogeneity in the GSMA are available (61) but have very low power (62) . Similarly, the GSMA would miss common genes with a low sibling recurrence risk that would be easily detectable in large association studies, such as the insulininduced gene 2 (INSIG2) gene, which was recently identified as a probable susceptibility gene for obesity by genome-wide association (63) . Since the risk allele has an odds ratio of only 1.2, its effect would be very difficult to detect by linkage, and indeed INSIG2 maps to 2q14.2, which was not identified as a locus for BMI or obesity in this study or in other individual linkage studies of obesity.
Variability of marker density within scans could also have an effect on the GSMA. Because of this, positive findings in the GMSA analysis may be conservative but negative results are less informative; no method can exclude linkage in any chromosomal region for a complex disorder, and GSMA data should not be interpreted in this way.
However, despite our lack of formal evidence for BMI and obesity loci from the meta-analysis, the highest ranking bins have been identified as candidates from other studies. This cannot be construed as formal support for the GSMA results, as BMI and obesity are related to many common traits and diseases, and coincidence of loci could easily occur by chance, but are worth noting as they may assist with mapping, candidate gene analysis, or functional studies.
Bins 13.2 and 13.3, corresponding to bands 13q13.2-q33.1, are the most significant results we observed both in the pooled analysis and in the subgroup with subjects of European ancestry, and achieved a significant ordered rank p values for linkage in the families ascertained through hypertension. One candidate gene from this region is the 5-hydroxy-tryptamine receptor 2A gene polymorphism (5-HTR2A, 46 cM), that resides on 13q14-q21 near to bin 13.2. 5-HTR2A has been associated with dietary energy and alcohol intake in obese people (64) , and also with anorexia nervosa (65) . Serotonin is a key mediator in the control of satiety mechanisms. Serotonin reduces food intake and is probably involved in weight regulation (66). Bin 2.2 (2p25.1-p23.2) has already shown linkage with several obesity-related phenotypes in addition to BMI (67), including skinfold thickness (68) , leptin (26, 69) , and adiponectin levels (70) . This region contains the gene encoding pro-opiomelanocortin, a locus previously linked to leptin levels and fat mass in Mexican-American, French, and black-American cohorts and shown to be mutated in obese humans. This region also contains the apolipoprotein B gene (2p24.2), which has been associated with BMI and percentage body fat (37) .
The most interesting results of the analysis are probably those obtained in the analysis focusing on the families ascertained through hypertension, which provide strong evidence of linkage. The significant ordered rank p values for this analysis show that the clustering of significant p values is more likely to reflect true BMI susceptibility loci in these regions (35) . That this subgroup provides the strongest evidence for linkage is perhaps surprising, as the subgroup is quite heterogeneous, with some researchers having excluded all diabetics in order to focus on "essential" hypertension. On the other hand, many hypertensive subjects also have a metabolic syndrome. In this analysis, we included 9 studies, 8 of which had already been analyzed together (53) , and so we would expect a concordance in the results. However, Wu et al. (53) identified a region on chromosome 3q using an identity-by-descent sharing analysis, which we did not find. This region showed a strong signal in only one of the 8 included studies. The different meta-analysis methods used may therefore explain these discordant results. Wu et al. (53) used both the IBD sharing method and the Fisher method for meta-analysis, which retain the magnitude of significance of the original studies, while GSMA is a rank based statistic and a single region with a strong linkage signal is less likely to be identified unless it is replicated across studies. In contrast, the region 12q14 -15, identified in our analysis, was also highlighted in this previous metaanalysis, although only in the analysis using the Fisher method, nonetheless indicating that this may well be a region of true linkage.
The genes mapping to these loci could either be genes solely relating to BMI, which have nothing to do with hypertension, genes that have a pleiotropic effect on both phenotypes, or genes that are primarily hypertension genes but influence BMI in this population only. A hypertension candidate gene is also already known to be located in the region 12q14 -15, arginine vasopressin receptor 1A. In the other regions that we identified here, cyclooxygenase 1 and dopamine beta-hydroxylase are found in 9q32-q33.3 and 9q34, respectively, corresponding to bin 9.5; angiotensinase C/Prolyl-CPY is found in 11q14 (bin 11.4) and endothelin receptor type B is found in 13q22 (bin 13.3.). No doubt, candidate genes for BMI could also be identified from these regions.
Finally, a comment on the the recent discovery of association between type 2 diabetes and obesity and the FTO gene on chromosome 16 (59) . This is one of the most convincing genetic findings in obesity, having been replicated in large samples sizes both within and independently of the original study (71, 72) . FTO maps to 16q12.2, which is within bin 16.3, one of the highest ranking bins for obesity in the present study ( Figure 1B) . This indicates that the other putative loci identified by this study, which are orphan loci in the sense that they have no unequivocally identified underlying gene, should be investigated further.
In summary, results from our meta-analysis, the largest GSMA study ever performed, failed to find strongly positive loci for BMI from linkage studies published to date. However, it does contribute to the body of evidence supporting the involvement of some loci in the complex polygenic regulation of BMI. Our findings indicate that BMI is most likely a highly heterogeneous trait, and as a general phenotype for linkage and association analysis is inferior to direct measures of adiposity or body composition, especially if consistent ascertainment criteria are not used.
